食品工业中常用益生素和化学益生素研究进展

本文综述益生素和化学益生素的定义、作用机理及近年在食品工业中常用益生素和化学 益生素的最新研究进展。     

益生菌及其在食品中应用进展

益生菌能够促进人体健康，在食品工业中有广泛的应用。该文综述了益生菌的概念、国内外研究现状、安全性和必备条件及其在食品加工中的应用。     

微生态调节剂研究进展

对微生态调节剂的种类、特性、作用及其机理，以及微生态调节剂在医药、食品工业、饲料添加剂中的应用等方面的研究进展作了系统综述。     

Bioavailability of calcium,magnesium and phosphorus in rats fed probiotic,prebiotic and synbiotic powder follow‐up infant formulas and their effect on physiological and nutritional parameters

The effect of infant formulas supplemented with functional ingredients on calcium (Ca), magnesium (Mg) and phosphorus (P) bioavailability was investigated in rats. Seven follow‐up infant formulas containing probiotics (Bifidobacterium bifidum and Bifidobacterium longum), prebiotics (galactooligosaccharides at 12, 50 and 100 g kg^?1) or synbiotics (bifidobacteria and galactooligosacccharides) were administered to weanling rats for 30 days. A 3 day mineral balance was performed over three periods (8–10, 18–20 and 28–30 days) to monitor mineral apparent absorption and retention ratios and physiological and nutritional parameters. Feeding rats on infant formula‐based diets showed high feed efficiency (≥0.46). It was found that infant formulas supplemented with probiotics and/or prebiotics for 30 days increased Ca, Mg and P bioavailability in rats. Mineral apparent absorption and retention ratios were higher than 90% for Ca and P and 80% for Mg during the first balance period regardless of the infant formula used, but they decreased during the next two balance periods. Although it was not possible to select one infant formula as the best to improve mineral absorption, the 100 g kg^?1 prebiotic and 50 and 100 g kg^?1 synbiotic infant formulas were the most efficient at increasing Ca, Mg and P bioavailability compared with the control group. Copyright © 2006 Society of Chemical Industry     

Therapeutic Spectrum of Nondigestible Oligosaccharides: Overview of Current State and Prospect

Functional oligosaccharides have emerged as valuable components of food and dietary supplements. Their resistance to digestion and fermentation by colonic microbes has given them the nutritional edge. Apart from implications as dietary fibers, sweeteners, and humectants, they are hailed as prebiotics. Their beneficial effects extend from antioxidant, anti‐inflammatory, immunomodulatory, antiallergic, hypotensive, hyperlipemic, neuroprotective to anticancer. The rising popularity of bioactive oligosaccharides has accelerated the search for their generation from new, sustainable sources. The surfacing crucial role in healthcare and unprecedented demand necessitates deeper investigation. The present review embodies an overview on various aspects of production, properties with emphasis on therapeutic applications of functional oligosaccharides. The biological efficacy and possible mechanisms of action of oligosaccharides have also been discussed.     

Effects of probiotic,prebiotic and synbiotic follow‐up infant formulas on large intestine morphology and bone mineralisation in rats

The effects of powder functional follow‐up infant formulas on the morphology of the large intestine and the bone mineral content in rats were investigated. Infant formulas were supplemented with probiotics (Bifidobacterium bifidum and Bifidobacterium longum), prebiotics (galacto‐oligosaccharides (4′‐GOS) at 12, 50 and 100 g kg^?1) or synbiotics (bifidobacteria and 4′‐GOS) and administered to seven groups of weanling rats over 30 days. After sacrificing the animals, the caecum and colon were removed and the luminal content pH and the crypt depth and cell density within the epithelial layer were measured. Results showed that groups fed synbiotic diets had significantly (P < 0.05) lower caecal and colonic content pH values compared with the control group. However, no test diet significantly modified the crypt depth or cell density in the caecum. In contrast, all seven test diets significantly increased (P < 0.05) the crypt depth in both the proximal and distal portions of the colon. There was a high correlation (Pearson correlation coefficient 0.870) between caecal and colonic content pH values. On the other hand, colonic content pH was negatively correlated with crypt depth in both the proximal and distal colon and with cell density in the distal colon. The authors previously reported increases in calcium, magnesium and phosphorus absorption using the same infant formulas. In the present study it was concluded that the increase in calcium absorption took place in the distal colon whereas magnesium absorption increased in both the proximal and distal colon, and their contents (especially that of calcium) increased in both the femur and tibia. Copyright © 2007 Society of Chemical Industry     

6种低聚糖对肠道益生菌生长情况的影响及代谢产物分析

该研究考察了水苏糖、低聚半乳糖、低聚果糖、菊粉、低聚木糖、抗性糊精等6种低聚糖对9种肠道益生菌的体外增殖作用,评价了不同低聚糖对不同益生菌的促生长和促产酸能力,并分析该54个发酵体系中乙酸和乳酸的最大产生量.结果 表明,6种低聚糖对各益生菌的促生长和促产酸能力不同,以水苏糖和低聚半乳糖的效果最为显著,表现出广谱的代谢能...     

益生菌在我国保健食品中的应用进展

由于益生菌类原料在调节肠道菌群和增强免疫力保健功能的研究比较系统,健康功效明确,因此,其在保健食品中应用越来越广泛,而且部分菌株已被国家市场监督管理总局明文规定允许用于婴幼儿食品的开发.随着科学技术的快速发展以及相关研究的不断深入,益生菌类原料具有的其它保健功能不断被发掘,而且作用机理也不断明晰,这为其在保健食品行业的...     

Overview of the Mechanistic Potential of Probiotics and Prebiotics in Cancer Chemoprevention

Despite of strides in modern cancer therapeutic strategies, there has not been a successful cure for it until now and prognostic side effects and substantial toxicity to chemotherapy and subsequent homeostatic imbalance remains a major concern for professionals in this field. The significance of the human microbiome in the pathogenesis of cancer is being recognized, documented, and established worldwide. Probiotics and prebiotics are some of the most extensively researched approaches to modulate the microbiota for therapeutic purposes, and research on their potential to prevent and treat cancer has sparked an immense amount of interest. The characteristics of probiotics and prebiotics allow for an array of efficient applications in cancer preventive measures. Probiotics can also be administered coupled with chemotherapy and surgery to alleviate their side effects and help promote the effectiveness of chemotherapeutic drugs. Besides showing promising results they are accompanied by potential risks and controversies that may eventually result in clinical repercussions. This review emphasizes the mechanistic potential and oncosuppressive effects of probiotic and prebiotics through maintenance of intestinal barrier function, modifying innate immune system, immunomodulation, intestinal microbiota metabolism, inhibition of host cell proliferation, preventing pathogen colonization, and exerting selective cytotoxicity against tumor cells.     

Chilled Milk-based Desserts as Emerging Probiotic and Prebiotic Products

Nowadays, food companies are endeavoring to differentiate their products through creative segmentation and positioning strategies based on superior functionality and quality. Some kinds of dairy desserts have shown a great market potential, as a function of consumers interested in healthier and functional products with fine taste and mouthfeel. In this context, chilled dairy desserts are emerging as attractive options for the incorporation of probiotic cultures and prebiotic ingredients, as seen in the previous launches from the food industry, as well as in the growing number of scientific studies dealing with this subject published in the last years. The main aspects involved in the development of probiotic and/or prebiotic dairy desserts for storage under refrigerated conditions are presented in this review.     

Review on potential non-dairy synbiotic beverages: a preliminary approach using legumes

In the past few years, certain functional foods have gained consumer acceptance like those containing synbiotics (a blend of both prebiotics and probiotics) in different food systems. Synbiotics enhance gut functionality and confer health benefits to humans. However, due to the limitations exerted by dairy-based matrices like lactose intolerance, milk allergies, limited shelf life and inclination towards veganism, consumer’s interest in non-dairy foods has increased. Among the non-dairy matrices, legumes (such as chickpeas, kidney beans, lupin) are the less explored areas with the majority focus on only soya beans. The present review gives brief information about the different research associating with various legume-based probiotics, prebiotics and synbiotic foods narrowing down specifically to beverages. The integration of such information will allow the researchers to explore product development using new prebiotic ingredients that have not been studied in much detail and hold an exceptional potential to be employed in the synbiotic food industry.     

Fermentation Capabilities of Bifidobacteria Using Nondigestible Oligosaccharides, and Their Viability as Probiotics in Commercial Powder Infant Formula

The species Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum biotype infantis (Spanish type culture collection), and Bifidobacterium longum (Morinaga nutritional foods) were evaluated in vitro in the presence of 4 commercial nondigestible oligosaccharides (NDO) (short‐chain fructooligosaccharides [SCFOS] [degree of polymerization, DP: 2–3], inulin [DP: 10–0], oligofructose [DP: 2–0] and 4′‐galactosyllactose [4′‐GOS] [DP: 3–]). Each species was incubated anaerobically in tryptone phytone yeast (TPY) broth for 7 d with NDO. Every 24 h, bifidobacteria growth was evaluated by means of broth turbidity as optical density at 600 nm. Moreover, another sample was collected for pH culture measurement. Results showed that inulin was the substrate with the least effect on the stimulation of bifidobacteria growth and pH decrease. On the last day of incubation, the substrate 4′‐GOS stimulated bacterial growth more strongly and produced a larger decrease in culture broth pH than the other substrates. On the other hand, B. bifidum and B. longum showed a greater growth with 4′‐GOS. In a 2nd study, these 2 bifidobacteria species were added to a powder follow‐on probiotic infant formula. The viability of the bifidobacteria during the formula's period of consumption was evaluated in 2 studies of 6 and 14 d. Both corresponded to the minimum and maximum time of consumption of the formula according to the manufacturer's directions. It was found that, although in both studies bifidobacteria counts decreased significantly (P < 0.05) with time, they were always above the recommended addition level (10⁶ colony‐forming units [CFU]/g) at the time of sale for dairy products by the Intl. Standard of Fédération Internationale de Laiterie/International Dairy Federation (FIL/IDF). Moreover, because the pH of the reconstituted formula was always close to neutrality (from 6.74 to 7.06), the number of bacteria did not drop below the recommended level.     

益生菌的研究进展

益生菌对人类的营养和健康有着非常重要的意义,在食品、医药和饲料工业中都有广泛的应用.本文综述了益生菌的种类、作用机理、敏感性、安全性及其在食品中的应用.     

The effect of co-encapsulation of Lactobacillus rhamnosus GG ATCC 53103 with inulin on alginate/chitosan matrix: the viability in fermented soy blend and simulated digestive system

This research verified the ability of Lactobacillus rhamnosus encapsulated with inulin to tolerate the simulated digestive system and their viability in a soy blend. Probiotic encapsulated in alginate-chitosan matrix without inulin presented a better encapsulation efficiency (80.92%) than encapsulation with inulin (57.39%). On the 28th day, the count of probiotics decreased by 3.42 and 1.99 logarithmic cycles of free and encapsulated cells without inulin, respectively. In contrast, the microorganisms encapsulated with inulin showed an increase of 1.26 logs CFU g⁻¹. During gastrointestinal simulation, cell counts decreased by 0.78, 1.55 and 1.95 CFU g⁻¹ logs for encapsulated cells without inulin, free and encapsulated with inulin, respectively. Sensory panellists liked the fermented soy blend with encapsulated lactobacilli, and this result shows the possibility to create new probiotic foods of plant origin. Therefore, the alginate/chitosan matrix can be considered adequate for the encapsulation of L. rhamnosus. The inulin reduces the encapsulation efficiency and increases the cell loss in gastrointestinal simulation. Considering cellular losses, the best option for preparing a fermented soy blend is to use L. rhamnosus encapsulated without inulin.     

Prevention of infections by probiotics

'Viable bacteria that exhibit beneficial effects for health based on improvement of balance of intestinal bacterial flora' was the most common definition of probiotics, but the diversity of their action mechanisms, including immune regulation, has been clarified, and probiotics have recently been broadly defined as 'live microorganisms which when administered in adequet amounts confer a health benefit on the host'. Coined words such as prebiotics, describing non-digestible food fiber components that contribute to host health by activating proliferation and function of beneficial intestinal bacteria, and synbiotics, describing a combination of probiotics and prebiotics have also been established as medical expressions. In this report, clinical studies of probiotics, prebiotics, and synbiotics on prevention of infection by various infectious diseases in humans are reviewed. The effects of and action mechanisms against sporadic intestinal infectious diseases that are difficult to investigate in humans (enterohemorrhagic Escherichia coli and Salmonellosis) in experimental animal models are also reviewed. Finally, points necessary for clarification of the role of probiotics in health care, and their functions in health care foods are discussed.     

儿童食物过敏及其饮食干预治疗研究进展

儿童食物过敏为儿童食品安全带来巨大隐患。随着技术手段的发展和生活水平的提高,儿童食物过敏检测率和发病率大幅增加。鉴于食物过敏原种类的复杂性,远离过敏源的食物管理治疗方法无法满足儿童的营养需求,因而,饮食辅助及替代治疗或称\     

口腔益生菌的研究现状

口腔是一个复杂而完整的微生态系统。生活方式、外源性致病菌等外源因子可扰乱口腔微生物组与其宿主之间的共生关系引发龋齿、牙周炎、牙龈炎、口臭等口腔疾病。益生菌是一类活的并对人类机体局部或全身性健康都具有有益作用的微生物。传统上,益生菌被广泛用于功能性食品、医药保健、饲料等各个领域,最常见的用途是治疗或预防胃肠道感染和疾病,改善肠道健康。近十年,各种研究表明益生菌可通过抑制致病菌生长,改善口腔微生物菌群,调节口腔免疫力等方式对各种口腔疾病产生积极的防治效果。作为一种新兴的机体健康维护概念,维护口腔健康的益生菌及其作用机制日益受到国内外学者的密切关注,综述了口腔益生菌在常见口腔疾病中的潜在作用机制,阐述了利用口腔益生菌在防治口腔疾病时所面临的重要问题,同时在口腔益生菌未来的发展趋势和开发方向等方面剖析如何更好地利用口腔益生菌驱动健康食品产业发展,以期为口腔益生菌的深入研究及其在食品工业中的开发应用提供相应参考。     

益生菌制剂及其发酵性乳制品

综述了益生菌的概念和益生菌菌株的选择标准、国外益生菌产品的发展状况、益生菌作为新型酸奶发酵剂的使用情况，以及益生酸奶的生产与消费情况。     

浅谈益生菌的保健作用

对益生菌的定义及保健作用做了系统的阐述,包括营养作用、改善胃肠道功能、增强机体免疫力、降低胆固醇、抗肿瘤、延年益寿的作用;其次说明了补充益生菌对人体健康的必要性。目前,益生菌应用在一系列的功能食品上,对人体的健康有着极大的益处。